bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
PATHTS5092

Order Name:
DISH HER-2 (Outside lab)

 
Useful For:
To figure out if breast cancer cells are HER2-positive.
 
Methodology:
Dual in situ hybridization (DISH)
 
 
 
Test Code:
PATHTS5092

Order Name:
DISH HER-2 (Outside lab)

 
Collection Specimen Or Container:
Paraffin embedded tissue block
 
Specimen Testing Type:
Paraffin embedded tissue block
 
Sub Mission Container:
Paraffin embedded tissue block
 
Rejection Criteria:
Paraffin embedded tissue block was insufficient for testing
 
Specimen Stabillity:
 
Specimen Type Temperature
paraffin embedded tissue block Room temperature
 
 
 
Test Code:
PATHTS5092

Order Name:
DISH HER-2 (Outside lab)

 
Method detail:
Dual in situ hybridization (DISH)
 
Schedule:
Tested daily, at 07:00 am. - 06:00 pm.
 
Turnaround Time:
2 weeks
 
Performing Location:
Surgical Pathology, Laboratory Department (Outside lab), Tel.14146
 
 
 
Test Code:
PATHTS5092

Order Name:
DISH HER-2 (Outside lab)

 
 
Clinical Information:
HER2-positive breast cancers make too much of the HER2 protein, which receives signals telling the breast cancer to grow. About one out of every four breast cancers is HER2-positive. Figuring out the HER2 status of a breast cancer is an important step in deciding on a treatment plan. The targeted therapy medicines Herceptin (chemical name: trastuzumab) and Tykerb (chemical name: lapatinib) are used to treat HER2-positive breast cancers.
 
Clinical Reference:
1.https://www.breastcancer.org/symptoms/testing/types/inform_her2_dual_ish (Retrieved: 1 Feb 19)